Walleye Trading
AXSM icon

Walleye Trading’s Axsome Therapeutics AXSM Stock Holding History

Walleye Trading’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,219
Closed -$223K – 4126
2025
Q4 		$223K Buy
1,219
+880
+260% +$123K ﹤0.01% 3333
2025
Q3 		$41.2K Sell
339
-1,777
-84% -$200K ﹤0.01% 4012
2025
Q2 		$221K Sell
2,116
-25
-1% -$2.65K ﹤0.01% 3186
2025
Q1 		$250K Buy
+2,141
New +$244K ﹤0.01% 2953
2023
Q3 		– Sell
-5,168
Closed -$386K – 4989
2023
Q2 		$371K Buy
+5,168
New +$381K ﹤0.01% 2995
2022
Q3 		– Sell
-22,506
Closed -$1.12M – 5028
2022
Q2 		$862K Buy
22,506
+11,945
+113% +$378K ﹤0.01% 2366
2022
Q1 		$437K Sell
10,561
-21,439
-67% -$665K ﹤0.01% 3045
2021
Q4 		$1.21M Sell
32,000
-12,440
-28% -$458K ﹤0.01% 2066
2021
Q3 		$1.47M Buy
44,440
+43,942
+8,824% +$1.71M 0.01% 1855
2021
Q2 		$34K Buy
+498
New +$29.9K ﹤0.01% 4727
2020
Q2 		– Sell
-4,351
Closed -$335K – 4229
2020
Q1 		$256K Sell
4,351
-51,105
-92% -$4.16M ﹤0.01% 2417
2019
Q4 		$5.73M Buy
+55,456
New +$2.24M 0.04% 509
2018
Q4 		– Sell
-28,323
Closed -$98K – 4612
2018
Q3 		$98K Hold
28,323
– – ﹤0.01% 4221
2018
Q2 		$91K Hold
28,323
– – ﹤0.01% 4087
2018
Q1 		$69K Buy
+28,323
New +$84.8K ﹤0.01% 4044

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Walleye Trading's AXSM Position: Q1 2026 in Review

Walleye Trading sold out of Axsome Therapeutics (AXSM) in Q1 2026, closing a stake of 1,219 shares — an estimated $223K sold.

Walleye Trading first reported a position in AXSM in Q1 2018 and held it in 15 quarters. The position peaked at $5.73M in Q4 2019. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Walleye Trading reported no remaining Axsome Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Walleye Trading sold 1,219 Axsome Therapeutics shares in Q1 2026, an estimated $223K.
  • Walleye Trading first reported a position in Axsome Therapeutics in Q1 2018 and held it in 15 quarters.
  • Walleye Trading's Axsome Therapeutics position peaked at $5.73M in Q4 2019.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.